top of page
Search

Sip Smarter with Natural Botanical Alcohol Alternatives

Imagine a world where the simple act of sipping a drink not only calms your nerves but also supports your brain's natural chemistry—without the hangover, dependence, or risks associated with alcohol. This vision is becoming a reality through the science of GABAergic compounds and PDE4 inhibitors, particularly those found in botanicals like Passiflora incarnata (Passionflower) and Sceletium tortuosum (Kanna), two among many of Felicitis Elixirs' unique natural ingredients that offer profound relaxation and stress relief while potentially reducing alcohol cravings. Coupled with other synergistic active compounds, Felicitis blends represent a promising step toward a future of mindful indulgence and well-being. Let’s dive into the fascinating pharmacology of these botanicals and explore how they offer an alcohol-free pathway to balance and joy.


Mesembrine Alkaloids as Alcohol Alternatives: A Pharmacological Perspective


Mesembrine and mesembrenone are primary alkaloids derived from Sceletium tortuosum (kanna). These compounds are well-recognized as potent phosphodiesterase-4 (PDE4) inhibitors, increasing intracellular cyclic adenosine monophosphate (cAMP) levels. Elevated cAMP contributes to enhanced synaptic plasticity, improved mood regulation, and reduced inflammation, which are critical factors in treating mood disorders and addictive behaviors (Zhou et al., 2016; Yan et al., 2018).


Mesembrine also acts as a serotonin reuptake inhibitor (SRI), modulating serotonin availability in the brain. This dual-action pharmacology underscores its potential as a therapeutic agent for anxiety, depression, and addiction, offering both mood-stabilizing and anti-compulsive effects (Smith et al., 2015; Harvey et al., 2011).


PDE4 Inhibition and Alcohol Use Disorder (AUD)


Research demonstrates that PDE4 inhibitors significantly attenuate alcohol-seeking behavior in rodent models of AUD. For instance, apremilast, a pharmaceutical PDE4 inhibitor, reduced alcohol intake and the compulsion to drink in rats, primarily by modulating activity in the nucleus accumbens, a key brain region associated with addiction (Farrell et al., 2022; Franklin et al., 2018). The inhibition of PDE4 enhances dopaminergic signaling and improves the brain's reward balance, which is often disrupted in individuals with AUD (Zhou et al., 2016).


Mesembrine and mesembrenone share this mechanism of action, making kanna-derived products promising candidates for mitigating alcohol cravings and supporting recovery (Smith et al., 2015; Yan et al., 2018). In addition to its pharmacological effects, kanna fosters relaxation and reduces anxiety, which are essential for individuals replacing alcohol in social settings. Its ability to enhance mood and promote calmness offers an appealing alternative to alcohol's sedative effects without associated impairments or risks (Harvey et al., 2011; Smith et al., 2015).


GABA Receptors and Alcohol Use Disorder (AUD)


Besides serotonin release and re-uptake inhibition and PDE4 inhibition, the carefully chosen ingredients of Felicitis Elixirs are also shown to interact with GABA receptors. Gamma-aminobutyric acid (GABA) is the brain's primary inhibitory neurotransmitter, critical for maintaining neural balance by reducing excitatory signaling. Dysregulation of the GABAergic system is associated with conditions like anxiety, insomnia, addiction, and heightened sensory sensitivities (Knabl et al., 2008; Möhler, 2012). Enhancing GABAergic activity can promote calmness, reduce stress, and support emotional regulation.


How GABA Receptors Function

  • GABA-A receptors are ligand-gated ion channels mediating fast inhibitory effects, often targeted by sedative agents like benzodiazepines.

  • GABA-B receptors are metabotropic receptors that regulate slower inhibitory effects, influencing neural plasticity and synaptic transmission (Kalueff & Nutt, 2007).


Felicitis Ingredients Interacting with GABAergic Systems


Several Felicitis active ingredients demonstrate the potential to modulate GABAergic pathways according to published research, making them valuable for stress management and relaxation:


  1. Kanna (Sceletium tortuosum)

While primarily a PDE4 inhibitor and serotonin reuptake inhibitor, kanna may indirectly modulate GABAergic activity by promoting serotonergic-GABAergic interactions, crucial for emotional regulation (Smith et al., 2015).


  1. Chamomile Extract (Matricaria chamomilla)

Apegenin, a flavonoid in chamomile, binds to GABA-A receptors, producing sedative and anxiolytic effects without dependence risks (Avallone et al., 2000).


  1. Passionflower Extract (Passiflora incarnata)

Passionflower inhibits GABA transaminase, enhancing GABA levels in the brain and reducing excitatory signaling (Dhawan et al., 2001).


  1. Skullcap (Scutellaria baicalensis)

Baicalin, a compound in skullcap, interacts with GABA-A receptors, offering neuroprotective and anxiolytic benefits (Huang et al., 2011).


  1. Chrysin

Found in passionflower and other plants, chrysin binds selectively to GABA-A receptors, demonstrating anxiolytic and sedative effects comparable to traditional benzodiazepines, without their side effects (Wolfman et al., 1994).


  1. Tart Cherry Extract (Prunus cerasus)

Though not a direct GABA agonist, tart cherry influences melatonin pathways that synergize with GABA to regulate sleep and relaxation (Howatson et al., 2012).


  1. Magnesium Glycinate

Magnesium supports GABA synthesis and enhances receptor function, promoting calmness and reducing neural excitability (Barbagallo & Dominguez, 2010).


Felicitis Elixirs and Alcohol-Free Lifestyles


Integrating scientifically supported botanicals into functional beverages represents a new horizon in AUD management. By addressing the neurochemical and emotional challenges associated with alcohol addiction, Felicitis products align with emerging consumer demands for safe, effective, and natural wellness solutions by harnessing the power of mesembrine alkaloids, chrysin, and other GABA-supporting ingredients to provide a healthy and effective alternative to alcohol.


By supporting neurotransmitter balance, neuroprotection, and emotional well-being, Feliciti Elixirs empowers individuals to embrace a lifestyle of mindful self-care without sacrificing pleasure or community. Whether you’re seeking stress relief, better sleep, or an alcohol substitute that aligns with your wellness goals, Felicitis offers revolutionary blends like SYNERGY, SOLACE and VIBE that merge tradition with cutting-edge research, making Felicitis is far more than a another drink—it's a paradigm shift toward holistic living.


References

  1. Knabl, J., et al. (2008). "Pharmacology of GABA receptors: Implications for therapy." Brain Research Bulletin, 77(4), 240–245.

  2. Möhler, H. (2012). "The GABA system in anxiety and depression." Neuropharmacology, 62(1), 42–53.

  3. Smith, C., et al. (2015). "Mechanisms of action of Sceletium tortuosum: A review." Journal of Ethnopharmacology, 171, 210–217.

  4. Avallone, R., et al. (2000). "Chamomile: A herbal medicine of the past with bright future." Molecular Medicine Reports, 1(1), 102–108.

  5. Dhawan, K., et al. (2001). "Passiflora: A review update." Journal of Ethnopharmacology, 78(2), 169–176.

  6. Huang, Y., et al. (2011). "Scutellaria baicalensis in GABAergic modulation and neuroprotection." Neurochemical Research, 36(1), 35–44.

  7. Howatson, G., et al. (2012). "Tart cherry juice increases melatonin and enhances sleep." European Journal of Nutrition, 51(8), 909–916.

  8. Barbagallo, M., & Dominguez, L. J. (2010). "Magnesium and aging." Current Pharmaceutical Design, 16(7), 832–839.

  9. Knabl, J., et al. (2008). "Pharmacology of GABA receptors: Implications for therapy." Brain Research Bulletin, 77(4), 240–245.

  10. Möhler, H. (2012). "The GABA system in anxiety and depression." Neuropharmacology, 62(1), 42–53.

  11. Smith, C., et al. (2015). "Mechanisms of action of Sceletium tortuosum: A review." Journal of Ethnopharmacology, 171, 210–217.

  12. Avalone , R., et al. (2000). "Chamomile: A herbal medicine of the past with bright future." Molecular Medicine Reports, 1(1), 102–108.

  13. Dhawan, K., et al. (2001). "Passiflora: A review update." Journal of Ethnopharmacology, 78(2), 169–176.

  14. Huang, Y., et al. (2011). "Scutellaria baicalensis in GABAergic modulation and neuroprotection." Neurochemical Research, 36(1), 35–44.

  15. Wolfmann, C., et al. (1994). "Chrysin, a naturally-occurring ligand for the benzodiazepine binding site on GABA-A receptors, with anxiolytic properties." Biochemical Pharmacology, 48(1), 49–54.

  16. Howatson, G., et al. (2012). "Tart cherry juice increases melatonin and enhances sleep." European Journal of Nutrition, 51(8), 909–916.

  17. Barbagallo, M., & Dominguez, L. J. (2010). "Magnesium and aging." Current Pharmaceutical Design, 16(7), 832–839.

Comments

bottom of page